Trials / Active Not Recruiting
Active Not RecruitingNCT04405557
The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor
Study on the Application of ctDNA in a Population at High-risk for Common Malignant Tumor
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 757 (estimated)
- Sponsor
- Geneplus-Beijing Co. Ltd. · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
This is a observational, multicenter study, monitoring the circulating tumor DNA (ctDNA) in people who is at risk of cancers，assessing the sensitivity and specificity of ctDNA detection in early screening of pan-carcinoma.
Detailed description
2000 patients with positive tumor protein markers or cancer screening were recruited. All patients were tested for ctDNA at enrollment and followed up at 6 months and 1 year. The study was completed at the time of cancer diagnosis or the longest follow-up time (1 year).
Conditions
Timeline
- Start date
- 2019-11-12
- Primary completion
- 2022-01-16
- Completion
- 2026-12-31
- First posted
- 2020-05-28
- Last updated
- 2025-09-04
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04405557. Inclusion in this directory is not an endorsement.